RECENT NEWS
- Alpheus Medical Raises $52M in Series B Round May 15, 2025
- Early Clinical Results of Sonodynamic Therapy February 25, 2025
- Alpheus Medical Announces Positive Phase 1/2 Trial Results November 24, 2024
- First Treated Patient in First-In-Human Clinical Trial for Novel Brain Cancer Treatment November 10, 2022
- FDA Grants Alpheus Medical Orphan Drug and Fast Track Designations July 13, 2022
- Formation of Advisory Board to Support Development of Novel Brain Cancer Treatment March 2, 2022
- Alpheus Medical closes $16m in Series A financing for novel glioma brain cancer treatment November 17, 2021